Full name
LUKMED 2 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
LUKMED 2 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. POŁUDNIOWA 37, 08-103 STARE OPOLE
TAX ID8212650729
Rate company:
LUKMED 2 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID8212650729
KRS0000948027
Share capital5,550.00 zł
address
UL. POŁUDNIOWA 37, 08-103 STARE OPOLE
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8212650729
REGON
366661940
KRS
0000948027
Legal form
limited liability company
Register Address
UL. POŁUDNIOWA 37, 08-103 STARE OPOLE
Date of registration in KRS
2022-02-01
Date of commencement of economic activity
2022-02-01
Act signature
RDF/689912/24/224
Pkd codes
86.90.E - Other human health activities notelsewhere classified
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.D - Paramedical activities
Payer VAT status
Active
Vat list bank account(s)
PL94 1050 1012 1000 0090 3199 9197 
PL19 1050 1012 1000 0090 3199 9189 PL42 1050 1012 1000 0090 3199 9163 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,5 | 1 | 0 | -95,4 |
EBITDA | 0,5 | 1 | 0,2 | -80,1 |
Short time liabilities | 1 | 0,9 | 1,5 | 68,8 |
Equity capital | 0,4 | 0,8 | 0 | -95,5 |
Operating profit (EBIT) | 0,5 | 1 | 0,2 | -81,2 |
Assets | 1,6 | 1,7 | 1,9 | 11,7 |
Net profit (loss) | 0,5 | 0,9 | 0 | -99,6 |
Cash | 0,5 | 0,2 | 0,3 | 89,3 |
Net income from sale | 2,8 | 3,7 | 3,1 | -16,9 |
Liabilities and provisions for liabilities | 1,2 | 0,9 | 1,8 | 104,3 |
Working assets | 1,6 | 1,7 | 1 | -42,7 |
Depreciation | 0 | 0 | 0 | 31,8 |
% | % | % | p.p. | |
Profitability of capital | 114,7 | 113,6 | 10,6 | -103 |
Equity capital to total assets | 26,8 | 46,4 | 1,9 | -44,5 |
Gross profit margin | 17,7 | 26,8 | 1,5 | -25,3 |
EBITDA Margin | 19,1 | 28,4 | 6,8 | -21,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 138 | 90 | 182 | 92 |
Current financial liquidity indicator | 1.3666601181030273 | 1.864366054534912 | 0.6109120845794678 | -1,3 |
Net dept to EBITDA | -0.03449887037277222 | 0.26275545358657837 | 4.865354537963867 | 4,6 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdfuses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.